Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two MDUK ONMC professors honoured by the Academy of Medical Sciences

The Academy of Medical Sciences, the independent body in the UK representing the diversity of medical science, has announced the election of fifty new Fellows, including two academics from the MDUK Oxford Neuromuscular Centre.

A new research centre tackles neuromuscular diseases


The launch of the MDUK Oxford Neuromuscular Centre marks an exciting new stage in the partnership between Muscular Dystrophy UK and the University of Oxford, with the goal of delivering new experimental medicines and developing enhanced clinical trial capacity in adult and paediatric neuromuscular diseases.

First steps towards treating myotonic dystrophy type 1

Collaborative research between teams from the Department of Paediatrics and the Institut de Myologie shows how antisense oligonucleotides can penetrate muscles to treat myotonic dystrophy type 1, a rare muscle disease.

NHS England to fund Spinraza drug, treating children with Spinal Muscular Atrophy

Spinraza – the first treatment for the rare condition spinal muscular atrophy (SMA) – is set to be available for NHS use for children and adults with SMA Types 1, 2 and 3.

Bake Sale for MDUK Oxford Town and Gown Support

MDUK Oxford Neuromuscular Centre Researchers Raise Funds for their runners in the MDUK Oxford Town and Gown

World-leading neurologist appointed to Professorship at MDUK Oxford Neuromuscular Centre

Acclaimed clinical researcher, Professor Laurent Servais, has been appointed Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre.

MDUK-Oxford University partnership

Changing the landscape for clinical trials by developing a major centre in the UK.